Biopsy Forceps Market Outlook: Size, Share, Trends, Growth Analysis, Competitive Landscape & Forecast, 2022-2033

North America Biopsy Forceps Market

North America accounted for 37%–40% of global revenue in 2025 and is projected to register a CAGR of 8.5%–9.2% during 2026–2033. The region benefits from high endoscopy procedure volumes, well-established healthcare infrastructure, favorable reimbursement systems, and strong adoption of advanced minimally invasive technologies. The Biopsy Forceps Market share remains the highest globally due to increasing colorectal cancer screening, growing bronchoscopy procedures, and widespread availability of specialized endoscopy centers.

• Hospitals and ambulatory surgical centers increasingly adopt high-performance disposable biopsy forceps to improve infection control while reducing device reprocessing requirements and operational complexity.
• Expanding colorectal cancer screening initiatives continue increasing gastrointestinal endoscopy procedures, supporting sustained demand for precision biopsy instruments across healthcare facilities.
• Healthcare providers increasingly invest in advanced endoscopy systems integrating high-definition visualization with precision tissue sampling technologies.
• Strong regulatory oversight encourages adoption of clinically validated biopsy devices meeting stringent safety, performance, and quality standards.
• Medical device manufacturers continue strengthening regional distribution networks and clinical education programs supporting wider physician adoption.

US Biopsy Forceps Market

The United States contributes approximately 30%–33% of global revenue in 2025 while expanding at a CAGR of 8.6%–9.3% through 2026–2033. Growing cancer awareness, expanding outpatient diagnostics, favorable reimbursement policies, and increasing adoption of minimally invasive procedures continue driving sustained market growth.

• Gastrointestinal cancer screening programs continue generating high procedural volumes requiring reliable tissue acquisition devices across hospitals and outpatient centers.
• Pulmonary diagnostics increasingly utilize advanced biopsy forceps during bronchoscopy procedures to improve early disease detection and diagnostic accuracy.
• Growing ambulatory surgery center expansion supports increasing demand for single-use biopsy devices with simplified workflow integration.
• Healthcare providers continue investing in advanced endoscopy platforms supporting improved visualization and precise tissue sampling.

Europe Biopsy Forceps Market

Europe represented 28%–31% of global market revenue in 2025 and is projected to grow at a CAGR of 9.0%–9.7% during 2026–2033. Strong public healthcare systems, increasing cancer screening initiatives, and expanding adoption of minimally invasive diagnostics continue driving regional demand. Germany remains the leading regional market, while Spain demonstrates one of the fastest growth rates.

• Germany maintains regional leadership through advanced hospital infrastructure, high procedural volumes, and continued investment in modern endoscopy technologies.
• Spain records robust growth supported by expanding outpatient diagnostics, healthcare modernization, and increasing awareness of preventive cancer screening programs.
• Growing preference for disposable biopsy forceps supports improved infection prevention and operational efficiency across healthcare facilities.
• Medical device innovation continues improving tissue sampling accuracy, ergonomic performance, and procedural safety for physicians.
• Increasing investment in hospital modernization supports broader adoption of advanced diagnostic instruments throughout Europe.

Asia Pacific Biopsy Forceps Market

Asia Pacific accounted for 24%–27% of global revenue in 2025 and is expected to register the fastest CAGR of 10.8%–11.6% during 2026–2033. The Biopsy Forceps Market growth is driven by expanding healthcare infrastructure, increasing endoscopy capacity, growing cancer incidence, and broader access to minimally invasive diagnostics. China leads regional demand, while India is projected to achieve the highest growth rate.

• China continues dominating regional demand through significant healthcare investment, hospital expansion, and increasing gastrointestinal diagnostic procedure volumes.
• India is anticipated to record a CAGR of 11.5%–12.3%, supported by expanding medical infrastructure, rising healthcare expenditure, and growing awareness of early cancer diagnosis.
• Japan and South Korea continue adopting technologically advanced biopsy devices supporting highly specialized diagnostic procedures.
• Expansion of private hospitals and specialty clinics accelerates procurement of advanced endoscopy instruments across emerging economies.
• Government initiatives supporting cancer screening programs continue strengthening long-term market demand throughout the region.

Rest of World Biopsy Forceps Market

The Rest of World region accounted for 7%–9% of global revenue in 2025 and is projected to grow at a CAGR of 9.4%–10.2% during 2026–2033.

South & Central America continues benefiting from healthcare infrastructure improvements and expanding diagnostic services, while the Middle East & Africa witness increasing investments in specialized healthcare facilities and minimally invasive diagnostic capabilities. Brazil leads regional demand, whereas Saudi Arabia records the fastest projected growth.

• Brazil continues expanding endoscopy capacity across public and private hospitals, supporting higher adoption of advanced biopsy instruments.
• Saudi Arabia is projected to achieve a CAGR of 10.3%–11.0%, driven by healthcare transformation initiatives, hospital expansion, and increasing investment in specialized diagnostic services.
• Growing medical tourism encourages healthcare providers to adopt advanced endoscopic technologies meeting international clinical standards.
• Rising prevalence of gastrointestinal and respiratory diseases supports increasing demand for minimally invasive biopsy procedures.
• Continuous healthcare modernization programs strengthen long-term procurement opportunities for advanced biopsy forceps across emerging healthcare systems.

Product Type

The Product Type segment forms the backbone of the biopsy forceps industry by enabling accurate tissue sampling across a wide range of endoscopic procedures. Flexible Biopsy Forceps accounted for 70%–73% of the market in 2025 and are projected to register a CAGR of 9.6%–10.3% during 2026–2033. The Biopsy Forceps Market scope continues expanding as healthcare providers increasingly adopt advanced flexible endoscopy systems that require highly maneuverable, precise, and reliable tissue acquisition instruments.

• Flexible Biopsy Forceps: Widely utilized during gastrointestinal endoscopy, bronchoscopy, urology, and other minimally invasive procedures owing to superior flexibility, enhanced accessibility, and consistent tissue sampling performance.
• Rigid Biopsy Forceps: Commonly employed in ENT procedures, gynecology, laparoscopy, and specialized surgical applications where greater instrument stability and controlled tissue collection are required.

Usability

The Usability segment reflects increasing emphasis on infection prevention, workflow efficiency, and healthcare cost optimization. Disposable biopsy forceps accounted for 56%–59% of global revenue in 2025 and are expected to register a CAGR of 10.1%–10.9% through 2026–2033 as healthcare providers prioritize patient safety and eliminate cross-contamination risks associated with device reprocessing.

• Disposable: Single-use biopsy forceps continue gaining preference across hospitals and ambulatory surgery centers by reducing sterilization requirements, minimizing infection risks, and improving procedural efficiency.
• Reusable: Reusable biopsy forceps remain widely adopted within high-volume healthcare facilities seeking long-term cost efficiency through standardized sterilization protocols and equipment lifecycle optimization.

Application

The Application segment reflects broad utilization of biopsy forceps across multiple diagnostic specialties. Gastrointestinal Endoscopy represented 42%–45% of market revenue in 2025 and is projected to grow at a CAGR of 9.5%–10.2% through 2026–2033. Rising gastrointestinal disease prevalence, colorectal cancer screening initiatives, and growing demand for minimally invasive diagnostics continue supporting sustained procedural volumes.

• Gastrointestinal Endoscopy: Increasing colorectal cancer screening, inflammatory bowel disease diagnosis, and upper gastrointestinal evaluations continue driving strong demand for precision biopsy forceps.
• Bronchoscopy: Rising incidence of pulmonary diseases and lung cancer screening programs continue supporting broader adoption of advanced tissue sampling devices.
• Urology: Diagnostic evaluation of urinary tract disorders and bladder abnormalities continues contributing to stable demand for specialized biopsy instruments.
• Gynecology: Cervical, uterine, and reproductive system diagnostic procedures increasingly utilize biopsy forceps for accurate tissue collection and disease diagnosis.
• Laparoscopy: Minimally invasive abdominal procedures continue incorporating precision biopsy instruments to improve surgical diagnosis while minimizing patient trauma.
• ENT: Otolaryngology procedures increasingly require specialized biopsy forceps supporting accurate diagnosis of throat, nasal, and ear disorders.

End-user

Hospitals and specialized diagnostic facilities continue representing the largest end-user base due to increasing endoscopy procedure volumes and expanding minimally invasive healthcare services. Hospitals & ASCs accounted for 52%–55% of market revenue in 2025 while advancing at a CAGR of 9.2%–10.0% through 2026–2033, supported by growing investments in advanced endoscopy equipment and outpatient care infrastructure.

• Hospitals & ASCs: High patient volumes, advanced diagnostic capabilities, multidisciplinary specialties, and increasing outpatient endoscopy procedures continue driving procurement of premium biopsy forceps.
• Specialty Clinics: Gastroenterology, pulmonology, urology, and gynecology clinics increasingly adopt advanced biopsy devices to improve diagnostic precision and procedural efficiency.
• Diagnostic/Endoscopy Centers: Independent diagnostic facilities continue expanding service offerings through investments in modern endoscopy platforms supporting faster diagnosis and minimally invasive patient care.